Results 321 to 330 of about 136,428 (330)

[Glucagon-like peptide 1 (GLP-1)].

MMW Fortschritte der Medizin, 2007
GLP-1 receptor agonists such as exenatide are a group of new therapeutic agents that mimic the gut-derived incretin hormone GLP-1. These drugs stimulate insulin secretion while suppressing glucagon secretion, inhibit gastric motility, reduce appetite and hence, food intake.
openaire   +1 more source

Glucagon-Like Peptide-1

2010
openaire   +1 more source

Glucagon-like-peptide-1

Reactions Weekly, 2014
openaire   +1 more source

[Glucagon-like peptide-1(GLP-1)].

Nihon rinsho. Japanese journal of clinical medicine, 2004
Glucagon-like peptide-1(GLP-1), an intestinal hormone secreted by L cells in response to luminal nutrients(carbohydrate and fat), enhances glucose-induced insulin secretion. Impairment of glucose-induced insulin secretion in patients with type 2 diabetes can be restored to near-normal by GLP-1 administration.
openaire   +1 more source

Glucagon-like peptide-1

Trends in Endocrinology & Metabolism
openaire   +2 more sources

Glucagon-Like Peptide-1

1994
openaire   +1 more source

Glucagon Like Peptide 1 Receptor

2018
openaire   +2 more sources

Glucagon-like Peptide-1 Analogues

2014
openaire   +1 more source

Glucagon-like Peptide-1 (7-37)

2007
S.J. Enna, David B. Bylund
openaire   +1 more source

[GLP-1 (glucagon-like peptide 1)].

Nihon rinsho. Japanese journal of clinical medicine, 2011
openaire   +1 more source